Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.32 |
| ▸ | SELE | P16581 | 1/20 | 0.32 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.31 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26658467 | 0.86 | KMT2A (0.42) | MEN1KMT2AKDM4CSMN1; SMN2 | |
| SCHEMBL26658517 | 0.86 | KMT2A (0.42) | MEN1KMT2AKDM4CSMN1; SMN2 | |
| SCHEMBL11762827 | 0.80 | MEN1 (0.38) | MEN1KMT2AKDM4C | |
| SCHEMBL2800616 | 0.80 | CCNA2 (0.33) | MEN1KMT2AGAA | |
| SCHEMBL964569 | 0.79 | MEN1 (0.37) | MEN1KMT2AKDM4C | |
| SCHEMBL26658421 | 0.79 | MEN1 (0.37) | MEN1KMT2AKDM4C | |
| SCHEMBL8897969 | 0.79 | MEN1 (0.37) | MEN1KMT2AKDM4C | |
| SCHEMBL26658594 | 0.79 | MEN1 (0.37) | MEN1KMT2AKDM4C | |
| SCHEMBL26658524 | 0.76 | MEN1 (0.35) | MEN1KMT2AKDM4C | |
| SCHEMBL965597 | 0.76 | MEN1 (0.35) | MEN1KMT2AKDM4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1997020823-A2 | 2-AMINO QUINAZOLINE DERIVATIVES AS NPY RECEPTOR ANTAGONISTS | NOVARTIS AG (CH) | 1997-06-12 | — | — | WO | disclosed |